ClinicalTrials.Veeva

Menu

Adequate Dosage of Sugammadex on Thyroid Surgery

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Thyroid Surgery

Treatments

Drug: Sugammadex 200 MG in 2 ML Injection

Study type

Interventional

Funder types

Other

Identifiers

NCT03689413
30-2018-45

Details and patient eligibility

About

This study was designed to compare two dosage of sugammadex after tracheal intubation for optimal condition of continuous intraoperative neuromonitoring in thyroid surgery to protect recurrent laryngeal nerve.

Full description

Vocal cord paralysis is not a rare complication in thyroid surgery. Nerve monitoring technique has been developed, and many clinicians use the technique for saving the concerned nerves. Many studies showed that the effect of sugammadex on reverse of neuromuscular blocking after tracheal intubation. However, optimal dosage was not founded for sugammadex.

This randomized controlled trial is to compare 1 mg/kg and 2 mg/kg as dosage of sugammadex for optimal continuous intraoperative neuromonitoring in thyroid surgery to prevent vocal cord paralysis.

Enrollment

102 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patients who need to open thyroid surgery

Exclusion criteria

  • Who doesn't agree to enroll
  • Who has to receive other drug rather than rocuronium for muscle relaxant

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

102 participants in 2 patient groups

1 mg/kg
Experimental group
Description:
For '1 mg/kg' group, sugammadex of 1 mg/kg (ex. 60 mg for 60 kg patient) will be administered to the assigned patient for this group after tracheal intubation. We will use Sugammadex 200 MG in 2 ML Injection for this.
Treatment:
Drug: Sugammadex 200 MG in 2 ML Injection
2 mg/kg
Active Comparator group
Description:
For '2 mg/kg' group, sugammadex of 2 mg/kg (ex. 120 mg for 60 kg patient) will be administered to the assigned patient for this group after tracheal intubation. We will use Sugammadex 200 MG in 2 ML Injection for this.
Treatment:
Drug: Sugammadex 200 MG in 2 ML Injection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems